MedTrace Logo

Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)

NCT06569602 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2024-10-31

No results posted yet for this study

Summary

This is a prospective, single-arm, multi-center, real-world study of an the Edwards EVOQUE system.

Conditions

Interventions

DEVICE

Transcatheter Tricuspid Valve Replacement

Replacement of the tricuspid valve through a transcatheter approach

Sponsors & Collaborators

  • Edwards Lifesciences

    lead INDUSTRY

Principal Investigators

  • Volker Rudolph, Prof. MD · Herz-und Diabeteszentrum NRW, Bad Oeynhausen

  • Fabien Praz, Prof. MD · Bern, Insespital, Switzerland

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2030-09-30
Completion
2033-09-30
FDA Device
Yes

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06569602 on ClinicalTrials.gov